At VIVA 2026, the Vascular InterVentional Advances conference, William A. Gray, MD, presented findings from a subgroup analysis ...
Gore & Associates announced FDA approval of an expanded indication for the company’s Viabahn VBX balloon expandable e ...
One-year results from the prospective, multicenter, single-arm PROMISE III trial evaluated transcatheter arterialization of the ...
A post hoc analysis of the randomized HI-PEITHO study examined potential predictors of major bleeding in patients with acute in ...
The ELEGANCE registry, which focuses on historically underrepresented populations to generate real-world evidence, evaluated en ...
Six-month results from Esprit BTK PAS were reported in patients with chronic limb-threatening ischemia (CLTI) treated with the ...
A study of computer-assisted vacuum thrombectomy (CAVT) met its predefined primary effectiveness and safety endpoints for the t ...
Results from the prospective, single-arm, multicenter POWER PAD II study demonstrated that the Pulse intravascular lithotripsy ...
Stryker Peripheral Vascular announced that the American Medical Association (AMA) Current Procedural Terminology (CPT) ...
Endovascular Engineering, Inc. (E2), a developer of technology for venous thromboembolism, announced FDA 510(k) clearance for b ...
A secondary analysis of the randomized SirPAD trial demonstrated lower rates of target-lesion revascularization (TLR) and major ...
The 24-month data from the entire cohort of the SUCCESS PTA study were presented by Thomas Zeller, MD, in a late-breaking clini ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results